Sign inJoin
Live
Live activity

The tape.

Every trade on Hero Market, live. Updates in place as new positions clear.

Window24h7dAll time
SideBothYESNO
MinAny size25+ SP100+ SP500+ SP
CategoryAllApparelAutoBeautyBeverageCapitalDealsFoodGLP-1HomeMediaPetRestaurantsRetailSleepSpiritsTechWellness
Clear filters
43 trades
TraderSideAmountMarketTime
@scarlettnash@scarlettnashNO+183 SPLilly vs Novo: bigger GLP-1 share gain in 2026: Novo Nordisk (semaglutide)
@quinnlopez@quinnlopezYES+250 SPWill AG1 (Athletic Greens) launch a new product SKU by July 15, 2026?
@micahpowell@micahpowellYES+250 SPFirst mushroom coffee to 1,000 Whole Foods doors: Cymbiotika
@sashapowell@sashapowellYES+115 SPWill Ro (Roman Health) raise a new funding round by June 30, 2026?
@sagevargas@sagevargasYES+174 SPWill AG1 (Athletic Greens) launch a new product SKU by July 15, 2026?
@annabrooks@annabrooksNO+210 SPSupplement brand pulled by FDA in 2026: HUM
@micahpowell@micahpowellNO+250 SPAthletic Greens (AG1) next major event: Strategic acquisition
@reesefisher@reesefisherNO+173 SPMost-funded GLP-1 weight-loss app of 2026: Ro Body
@sofiadiaz@sofiadiazNO+143 SPMost-funded GLP-1 weight-loss app of 2026: Other
@ameliadiaz@ameliadiazYES+119 SPFirst GLP-1 brand to 1M active subscribers: Sequence
@audenvega@audenvegaYES+171 SPEli Lilly Q2 2026 Mounjaro revenue band: $3.5B – $4.0B
@elladiaz@elladiazNO+241 SPOura IPO timing: No IPO filing
@reesefisher@reesefisherNO+120 SPOura IPO timing: Q1 2026
@annabrooks@annabrooksNO+250 SPLongevity startup IPO 2026: Elysium Health
@quinnlopez@quinnlopezNO+120 SPLongevity startup IPO 2026: Elysium Health
@micahpowell@micahpowellYES+250 SPWill AG1 (Athletic Greens) launch a new product SKU by July 15, 2026?
@sagevega@sagevegaNO+250 SPTirzepatide compounding outcome: Restricted with shortage carve-out
@sagevega@sagevegaNO+250 SPCBD sleep gummy market leader 2026: Sunday Scaries
@micahpowell@micahpowellNO+250 SPWill Function Health close a Series B by July 31, 2026?
@graceyoung@graceyoungYES+158 SPSupplement brand pulled by FDA in 2026: Ritual
@reesebennett@reesebennettNO+166 SPCPG founder who returns to active operating role 2026: Emily Weiss (Glossier)
@graceyoung@graceyoungNO+250 SPTop-selling sleep aid supplement 2026: Magnesium Glycinate (Thorne)
@junehale@junehaleNO+107 SPWill Ro (Roman Health) raise a new funding round by June 30, 2026?
@graceyoung@graceyoungYES+196 SPFirst retailer to launch private-label GLP-1 program 2026: Walgreens
@reesefisher@reesefisherYES+250 SPEli Lilly Q2 2026 Mounjaro revenue band: $3.0B – $3.5B
@hazelcole@hazelcoleNO+250 SPOura IPO timing: No IPO filing
@graceyoung@graceyoungYES+205 SPFirst GLP-1 telehealth to raise a mega-round in 2026: Sequence (Weight Watchers)
@junehale@junehaleYES+132 SPFunction Health next milestone 2026: No major milestone
@ameliashah@ameliashahNO+250 SPSmart mattress brand to hit $300M revenue first: Purple
@parkermoss@parkermossYES+250 SPEight Sleep's next funding milestone: Acquisition
@laneyoon@laneyoonYES+200 SPEight Sleep's next funding milestone: IPO filing
@graceyoung@graceyoungYES+243 SPFirst GLP-1 brand to 1M active subscribers: No brand discloses
@graceyoung@graceyoungYES+228 SPWill Function Health close a Series B by July 31, 2026?
@micahpowell@micahpowellYES+250 SPWill the FDA approve a generic semaglutide by July 31, 2026?
@wrencarrillo@wrencarrilloNO+217 SPHims's biggest 2026 acquisition: No acquisition
@sagevargas@sagevargasYES+188 SPApple Sleep feature launch 2026: Vision Pro sleep mask
@rowanalvarez@rowanalvarezNO+250 SPAthletic Greens (AG1) next major event: Strategic acquisition
@audenvega@audenvegaYES+250 SPBig-tech sleep acquisition 2026: Oura
@wrencarrillo@wrencarrilloNO+248 SPApple Sleep feature launch 2026: No major feature
@junemonroe@junemonroeYES+206 SPCPG founder who returns to active operating role 2026: None
@quinnlopez@quinnlopezNO+250 SPOura IPO timing: Q4 2026
@graceyoung@graceyoungYES+191 SPMost-funded GLP-1 weight-loss app of 2026: Calibrate
@harperdiaz@harperdiazNO+234 SPCardiovascular GLP-1 indication approval 2026: Zepbound (tirzepatide)